Tag: network
Top News
Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar:...
Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.
- Our Sponsors Ad -